Little by little….Cancer death rates fall, with a few exceptions - ABC News abcnews.go.com/Health/cancer-death-rates-fall-exceptions/story?id=78731311
The 2021 Annual Report to the Nation on the Status of Cancer is now out with good news. The overall annual cancer mortality rate continues to decline. That decline has accelerated for #LungCancer and #melanoma. www.cancer.gov/news-events/press-releases/2021/annual-report-nation-2021 pic.twitter.com/ahDGvEHMsI
Exclusive analysis of biotech, pharma, and the life sciences
By Theresa Gaffney July 8, 2021
The new report — released by the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention, and other collaborators — found that between 2014 and 2018, death rates dropped for 11 out of 19 of the most common cancers among men and 14 of the 20 most prevalent cancers among women.
Accelerating declines in lung cancer deaths may account for much of the overall progress seen in recent years, the authors of the report said. Over the past two decades, the death rate for lung cancer has declined even faster than the rate at which patients are diagnosed with the disease. And while part of the early success in preventing lung cancer can be attributed to the massive drop in smoking rates, the authors note the most recent downward trends seem to correspond with the approval of new treatments for non-small cell lung cancer that improved the likelihood of survival.
Death rates from melanoma also saw an accelerated decline in the past decade, despite a growing number of diagnoses. Like in lung cancer, authors point to the introduction of novel treatments around the same time as the turnaround on the death rate. New targeted and immune checkpoint inhibitors were approved by the Food and Drug Administration in 2011, one year before major declines in death rates were seen in women and two years before they were seen in men.
Farhad Islami, the lead author of the report and a scientific director at the American Cancer Society, said the findings point to areas where treatments or new advances are benefiting patients and underscore which forms of cancer may need more attention from scientists and research funding organizations.
“It’s important that people have timely access to quality treatment,” Islami said. “Not just any treatment, but something that evidence shows is effective.”
While the report showed improved survival rates for many patients over recent years, others, such as prostate, colorectal, or female breast cancers, have seen progress stalled or stopped. Breast cancer continues to be one of the three deadliest cancers for women of all races, and the most frequently fatal cancer for Hispanic women.
While the rates of death from breast cancer are declining, the pace of the decline has slowed over the past two decades, according to the report.
And across the board, racial health disparities persist. Black women and white women are diagnosed with breast cancer at similar rates, Islami said, but the mortality rate for Black women is 40% higher. Overall, cancer is more common among white individuals than Black individuals, but Black people die from cancer at higher rates.
Islami emphasized the importance of preventive measures for certain cancers, noting that while cancers related to smoking have continued to decrease, those related to excess body weight have increased. Early and consistent access to screenings has also been critical, he said, as demonstrated by the apparent effect of adapted screening guidelines for colorectal cancer.
From 2000 to 2010, the number of people between the ages of 50 and 75 who received a regular colonoscopy more than doubled from 19% to 55%. But between 2010 and 2015, that same rate only rose to 59%. While it’s not a clear cause and effect, this slowdown in screening uptake is closely correlated with slower improvements in the death rates from colorectal cancer.
Each year, the report on cancer is meant to provide guidance to clinicians in speaking directly with their patients. But Islami said that authors are also looking toward a wider audience.
“We hope that policymakers read the paper,” Islami said. “Many of these things need community-level policies to be implemented.”
There was an error saving your display name. Please check and try again.
Reporting from the frontiers of health and medicine
Read full article at STAT
08 July, 2021 - 04:12pm
Updated 8:29 AM ET, Thu July 8, 2021
Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.
08 July, 2021 - 04:12pm
08 July, 2021 - 01:14pm
The decline included men and women of all racial and ethnic groups.
The report, published by the Journal of the National Cancer Institute Thursday, includes data from 2001 to 2018, meaning it does not reflect cancer incidence or deaths rates during the COVID-19 pandemic.
The decline in cancer death rates held true for both men and women of all racial and ethnic groups. The report showed a decrease in death rates among 11 of the 19 most common cancers in men and 14 of the 20 most common cancers in women. That overall decline translates into an average 2.2% cancer death rate decrease per year for men and an average 1.7% decrease per year for women.
"The continued decline in cancer death rates should be gratifying to the cancer research community, as evidence that scientific advances over several decades are making a real difference in outcomes at the population level," Dr. Norman Sharpless, director of the National Cancer Institute, one of the groups that collaborated on the report, said in a statement.
Additionally, cancer incidence rates among women, children, adolescents and young adults rose between 2014 and 2018, the report found. The most common cancer among adolescents and young adults ages 15 to 39 was female breast cancer. Among children younger than 15, the most common cancers were leukemia, lymphoma and brain and nervous system cancers. Although the incidence of cancer is increasing among women, in general, cancer incidence rates are higher for men.
"I believe we could achieve even further improvements if we address obesity, which has the potential to overtake tobacco use to become the leading modifiable factor associated with cancer," Sharpless added.
24/7 coverage of breaking news and live events
08 July, 2021 - 11:41am
Death rates between 2014 and 2018 fell for 11 of the 19 most common cancers among men, and 14 of the 20 most common among women, according to the report from the American Cancer Society, Centers for Disease Control and Prevention, National Institutes of Health, and the North American Association of Central Cancer Registries.
The accelerating pace of decline in deaths from lung cancer and melanoma helped bring down cancer deaths between 2001 and 2018, the report said.
Reduced smoking rates and breakthroughs in cancer drug development have helped contribute to the overall decline, Karen Knudsen, chief executive officer of American Cancer Society, said in a press release.
Death rates increased for brain and other nervous system as well as pancreatic cancer in both sexes, oral cavity and pharynx cancers in men, and liver and uterus cancers in women.
The rate of decline in deaths slowed or even disappeared for some cancers, including female breast cancer.
The report found that overall cancer death rates decreased in every racial and ethnic group during the 2014-18 period, but added that death rates remained higher among Black people than Whites.
Reporting by Mrinalika Roy in Bengaluru; editing by Caroline Humer and Shinjini Ganguli
Our Standards: The Thomson Reuters Trust Principles.
08 July, 2021 - 10:26am
The report found that from 2015 to 2018, overall cancer fatality rates for men dropped 2.3 percent per year, faster than the 1.8 percent decline recorded each year from 2001 to 2015.
For women, deaths due to cancer dropped by 2.1 percent each year from 2015 to 2018, compared to 1.4 percent each year from 2001 to 2015.
“While we celebrate the progress, we must remain committed to research, patient support, and advocacy to make even greater progress to improve the lives of cancer patients and their families,” Knudsen added in a statement.
Despite the improvements, the study also noted a slowing down of previous declining trends for colorectal and female breast cancer death rates, and the fatality rate for prostate cancer leveled off.
Researchers said that death rates increased for a small group of cancers, including pancreatic, brain and other nervous system cancers for both men and women, as well as oral cavity and pharynx in males and liver and uterus cancers in females.
Obesity was cited as a main risk factor potentially influencing increases in case and death rates or deceleration of previous dropping trends for colorectal and female breast cancers.
NCI Director Norman “Ned” Sharpless said in a statement, “I believe we could achieve even further improvements if we address obesity, which has the potential to overtake tobacco use to become the leading modifiable factor associated with cancer.”
Meanwhile, Betsy Kohler, NAACCR’s executive director, said more attention should also be given to “evaluating health disparities,” specifically the “social factors that influence the health of the communities and access to health care.”
"Social and economic indicators, particularly based on small area assessments, are increasingly important to understanding the burden of cancer,” Kohler said in the statement.
The Hill 1625 K Street, NW Suite 900 Washington DC 20006 | 202-628-8500 tel | 202-628-8503 fax
The contents of this site are ©2021 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.
08 July, 2021 - 09:40am
The findings come from the ACS’s Annual Report to the Nation on the Status of Cancer, a joint project between the ACS, the North American Association of Central Cancer Registries (NAACR), and the federal government, including the National Cancer Institute and the Centers for Disease Control and Prevention. It’s based on data collected by the CDC as well as registry data from the NAACR between 2001 and 2018. The full report was published Thursday in the Journal of the National Cancer Institute.
“The declines in lung cancer and melanoma death rates are the result of progress across the entire cancer continuum—from reduced smoking rates to prevent cancer to discoveries such as targeted drug therapies and immune checkpoint inhibitors,” said Karen E. Knudsen, CEO of the American Cancer Society, in a statement from the organization. “While we celebrate the progress, we must remain committed to research, patient support, and advocacy to make even greater progress to improve the lives of cancer patients and their families.”
There are important caveats to this good news, namely the still ongoing covid-19 pandemic. People have visited the doctor less frequently during the pandemic for cancer-related treatment and screenings, particularly in the first wave last spring, which many experts believe will lead to an increase of advanced cancers that will be less treatable and more likely to be fatal. Some studies have already projected that these delays in care will lead to thousands of excess deaths over the next decade.
“It is encouraging to see a continued decline in death rates for many of the common cancers,” said Karen Hacker, director of the CDC’s National Center for Chronic Disease Prevention and Health Promotion. “To dismantle existing health disparities and give everyone the opportunity to be as healthy as possible, we must continue to find innovative ways to reach people across the cancer care continuum—from screening and early detection to treatment and support for survivors.”
Overall, cancer remains one of the top leading causes of death every year. In 2021, according to the ACS, there will be an estimated 1.9 million new diagnosed cancer cases and 608,570 cancer deaths.
So to get into a few specifics that you addressed in the article:
08 July, 2021 - 05:54am
The annual report of cancer deaths paints a mixed picture of the nation's effort to combat the second leading cause of death, experts say.
A link has been sent to your friend's email address.
A link has been posted to your Facebook feed.
Researchers are reporting the largest ever one-year decline in the U.S. cancer death rate, mainly because of advances in the treatment of lung tumors. (Jan. 8) AP Domestic
U.S. cancer death rates for men, women and communities of color are falling, but obesity and unequal access to care could threaten hard-fought gains over the past two decades, a new report shows.
The annual American Cancer Society report, which measures cancer cases and deaths through 2018, paints a mixed picture of the nation's effort to combat the second leading cause of death, said Farhad Islami, the report's lead author and American Cancer Society's scientific director of cancer disparity research.
Death rates for lung cancer and melanoma improved significantly, but recent progress on breast and colon cancer deaths slowed, and prostate cancer death rates flattened after years of decline, the report said.
Experts said long-standing efforts to curb cigarette smoking and tobacco use along with improved medical care have yielded significant improvements in lung cancer deaths.
"The decrease in smoking is a huge reason," said Dr. Otis Brawley, a professor at Johns Hopkins University and former chief medical officer at American Cancer Society. "Keep in mind it is not just lung cancer, but smoking causes 18 different cancers."
New medications to treat people with melanoma that spread to other parts of the body also improved survival rates, Islami said.
The new report, published in the The Journal of the National Cancer Institute, includes death rates by age, sex, race, and ethnicity from 2001 through 2018 based on death certificates reported to states and the Centers for Disease Control and Prevention's National Center for Health Statistics.
Overall, cancer death rates fell at a faster rate from 2015 to 2018 compared with rates since 2001. Cancer death rates for men dropped 2.3% per year from 2015 to 2018, a faster than 1.8% decline each year from 2001 to 2015. Among women, cancer deaths dropped 2.1% per year from 2015 to 2018, compared with 1.4% per year from 2001 to 2015.
Cancer death rates also dropped among all racial and ethnic group from 2014 to 2018. But death rates overall remain higher among Blacks compared with whites and other racial and ethnic groups.
Despite slowing death rates in most types of cancer for men and women, not all trends were positive. Death rates increased from cancer in the brain, nervous system and pancreas among men and women. In men, oral and throat cancers are on the rise, and liver and uterine cancers in women.
However, experts warn that obesity could soon overtake smoking as the nation’s main driver of new cancer cases. And the figures show positive strides on common cancers such as breast and colon cancers have slowed. One possible factor is rising obesity, Islami said.
Brawley agrees an "energy imbalance" of eating too much and not exercising enough is putting more Americans at risk for cancer. Brawley cited previous research that predicted such rising obesity and lack of exercise would usurp tobacco this decade as the leading cause of cancer
"Think about tobacco control pushing the rate down and energy imbalance pushing the rate up at the same time, "Brawley said. "And by the way, the cancers that are going up or the cancers that are not going down in death rate in this study are the ones most closely associated with energy imbalance."
The data does not captures cancer cases and deaths since the beginning of the COVID-19 pandemic in 2020, but researchers fear a slowdown in screening during lockdowns could mean doctors and patients are missing early-stage cases.
"They may be diagnosed a year later," Islami said. "Increasing the proportion of cancers at a more advanced stage will eventually translate to higher death rates, unfortunately."
© 2021 USA TODAY, a division of Gannett Satellite Information Network, LLC.
08 July, 2021 - 05:01am
Death rates for lung cancer and melanoma continued to drop for men and women in the U.S. between 2014 and 2018, according to an annual report with the National Cancer Institute.
Yes, but: For several other major cancers, however, like colorectal, breast and prostate, death rates increased — or saw previous improvements stall.
State of play: American deaths from cancer — the second-leading cause of death in the U.S. — have been on the decline for years. But it's not the same across the board, particularly when it comes to cancers related to obesity.
Death rates among women increased for five of the most common cancers such as uterus, liver, brain and pancreas. Death rates decreased for 14 cancers.
For men, death rates for five cancers including bones and joints, oral cavity and pharynx, brain and pancreas increased. Death rates decreased in men for 11 cancers.
By the numbers: Cancer death rates declined overall in every racial and ethnic group since 2001, but drops have accelerated in the last five years.
Still, overall cancer incidence is increasing in women, children and young adults.
Be smart: The analysis observes cancer rates and deaths up to 2018, but since last year, doctors have expressed concern the pandemic will lead to an uptick in cancer incidence and deaths and scale back the progress made between different race and ethnicities with the disease.
The National Cancer Institute estimated there will likely be 10,000 additional deaths over the next decade due to the drop in screening and treatments of breast and colorectal cancer during the pandemic.
What's happening: Several associations and government agencies have altered screening and prevention guidance in recent months to address increasing cancer incidence.
Screenings for colon cancer are now recommended by the U.S. Preventive Services Task Force at 45 instead of at 50 as of May, due to the disease increasingly occurring among adults younger than 50.
The group also recommended in March annual lung cancer screenings be conducted on those as young as 50 and to those with shorter smoking histories than previously thought necessary.
What they're saying: “The continued decline in cancer death rates should be gratifying to the cancer research community, as evidence that scientific advances over several decades are making a real difference in outcomes at the population level,” Ned Sharpless, director of the NCI, said in a statement.
“I believe we could achieve even further improvements if we address obesity, which has the potential to overtake tobacco use to become the leading modifiable factor associated with cancer," he added.
Packed restaurants, bars and stores and huge beer-drinking crowds at parks alongside Seoul's Han River in recent weeks have illustrated how the country has let its guard down despite a slow vaccine rollout.
(Reuters) -Eric Adams, the Brooklyn borough president and a former police captain, won the Democratic nomination for New York City mayor as a moderate who vowed to improve public safety and give voice to working-class residents. Adams' two closest rivals, former city sanitation chief Kathryn Garcia and civil rights lawyer Maya Wiley, conceded the race on Wednesday, a day after newly released vote totals from the June 22 election showed him maintaining a narrow lead. Adams' victory makes him the strong favorite in November's election in the heavily Democratic city - and could give national Democrats some signs of where voters stand as the party strives to maintain a fragile alliance between progressives and centrists in Washington.
Major improvements in survival were found for lung and skin cancer.
It may be Freedom Day on July 19 with the prospect of going maskless a real joy and relief for many but, for those with blood cancer, it will be a day more freedoms are taken from them. Tania Dineen Parish already can’t have dinner in the same room as her husband Paul, nor can she sleep with him in their marital bed. Paul has recently returned to his job in facilities management after a period of being furloughed and his increased risk from venturing outside and catching Covid already meant a po
Dogs don’t get high. They get sick. Take care of your pup by educating yourself and stashing your stash.
The illness, which affects many species commonly found in backyards in the US, causes the birds to stumble about and lose some control of their limbs.
At more than 69 feet in height, designers in Denmark have created the world's biggest sandcastle. The sandcastle was built to last until next February.
Yes, you can eat what you love and still lose weight.
Vermont has administered at least one vaccine dose to nearly 75% of its population. The milestone may indicate it has reached herd immunity.
Long months cloistered at home during lockdown have been hard on family life. Domestic violence has increased; relationships have been strained to breaking point, divorce has spiked around the world. But there are happier stories too, and I’m one of a fortunate group of older people who are glad to have shared this strange time with a compatible partner. It was also a chance for me to contemplate my previous marriage, which ended 30 years ago. Shortly before lockdown I had come across a manuscri
Job openings are at a record high and most companies are trying to hire, but they can't find enough workers even though millions of people are still unemployed. Why aren't they looking for work? When do they plan to find a job?
OxyContin maker Purdue Pharma’s plan to reorganize into a new entity that helps combat the U.S. opioid epidemic got a big boost as 15 states that had previously opposed the new business model now support it. The agreement from multiple state attorneys general, including those who had most aggressively opposed Purdue's original settlement proposal, was disclosed late Wednesday night in a filing in U.S. Bankruptcy Court in White Plains, N.Y. It followed weeks of intense mediations that resulted in changes to Purdue's original exit plan. The new settlement terms call for Purdue to make tens of millions of internal documents public, a step several attorneys general, including those for Massachusetts and New York, had demanded as a way to hold the company accountable.
Expect to struggle with communication in the coming weeks.
If you aren't already familiar with hunky Scottish actor Thomas Doherty, it's only a matter of time before you are. The Descendants alum is headed to the Upper East Side to play Max Wolfe on HBO Max's Gossip Girl reboot, and while it's unclear who Max may romance on the show, it seems like Thomas has a new love interest IRL.
The Copernicus Climate Change Service reported on Wednesday that June 2021 was the hottest ever in North America. It's not cooling down anytime soon
Fiji’s medical system is showing signs of strain as a coronavirus outbreak grows. The Ministry of Health says that due to the increase in cases, it will no longer test people for the virus in their homes in and around the capital. Fiji has reported 59 deaths from COVID-19 since the outbreak of the delta variant began in April.
None of the people who died had been vaccinated, officials said.
Greece will announce mandatory vaccinations for specific professional groups next week, the government said on Thursday after a recent spike in COVID-19 infections. "The government...has got the relevant recommendation by the national bio-ethics committee regarding mandatory vaccinations for specific professional groups," government spokeswoman Aristotelia Peloni told a briefing on Thursday. There has been debate about whether mandatory vaccinations are ethical, though a poll released by Greek Skai television on Wednesday showed the majority of Greeks were in favour of the move for specific groups dealing with the public.
After Brian Austin Green posted a tender pic of himself kissing Sharna Burgess, his ex Megan Fox shared that she's "grateful" for the Dancing With the Stars standout.
Chinese regulators decided last Friday to block new users from downloading the country's most popular ride-hailing app, Didi, just weeks after the company debuted on the New York Stock Exchange, sending the company's shares down as much as 25% and triggering a broad reevaluation of the risks of investing in Chinese stocks.
08 July, 2021 - 05:00am
Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death rates accelerated, and death rates for melanoma declined considerably in more recent years, reflecting a substantial increase in survival for metastatic melanoma. However, the report finds that for several other major cancers, including prostate, colorectal and female breast cancers, previous declining trends in death rates slowed or disappeared.
The report, appearing in JNCI: The Journal of the National Cancer Institute, also finds that overall cancer incidence rates continue to increase among females, children, and adolescents and young adults (AYA). All trends in this report cover the period before the COVID-19 pandemic.
The annual report is a collaborative effort among the American Cancer Society (ACS); the Centers for Disease Control and Prevention (CDC); the National Cancer Institute (NCI), part of the National Institutes of Health (NIH); and the North American Association of Central Cancer Registries (NAACCR).
The report shows a decrease in death rates for 11 of the 19 most common cancers among men, and for 14 of the 20 most common cancers among women, over the most recent period (2014-2018). Although declining trends in death rates accelerated for lung cancer and melanoma over this period, previous declining trends for colorectal and female breast cancer death rates slowed and those for prostate cancer leveled off. Death rates increased for a few cancers like brain and other nervous system and pancreas in both sexes, oral cavity and pharynx in males, and liver and uterus in females.
“The declines in lung cancer and melanoma death rates are the result of progress across the entire cancer continuum – from reduced smoking rates to prevent cancer to discoveries such as targeted drug therapies and immune checkpoint inhibitors,” said Karen E. Knudsen, MBA, PhD., Chief Executive Officer, American Cancer Society. “While we celebrate the progress, we must remain committed to research, patient support, and advocacy to make even greater progress to improve the lives of cancer patients and their families.”
An analysis of long-term trends in cancer death rates in this year’s report also shows that death rate declines accelerated in both males and females from 2001 to 2018. In males, a decline of 1.8% per year in 2001 to 2015 accelerated to a decline of 2.3% per year during 2015 to 2018. In females, a decline of 1.4% per year from 2001 to 2015 accelerated to a decline of 2.1% per year during 2015 to 2018. The report found that overall cancer death rates decreased in every racial and ethnic group during 2014 to 2018.
“It is encouraging to see a continued decline in death rates for many of the common cancers,” said Karen Hacker, MD, MPH, Director of CDC’s National Center for Chronic Disease Prevention and Health Promotion. “To dismantle existing health disparities and give everyone the opportunity to be as healthy as possible, we must continue to find innovative ways to reach people across the cancer care continuum–from screening and early detection to treatment and support for survivors.”
However, increases in cancer incidence and death rates or deceleration of previous declining trends for some other cancers such as colorectal and female breast cancers are likely due to risk factors such as obesity.
“The continued decline in cancer death rates should be gratifying to the cancer research community, as evidence that scientific advances over several decades are making a real difference in outcomes at the population level,” said Norman E. “Ned” Sharpless, MD, Director of the National Cancer Institute, of the National Institutes of Health. “I believe we could achieve even further improvements if we address obesity, which has the potential to overtake tobacco use to become the leading modifiable factor associated with cancer.”
The authors report that cancer death rates continued to decrease among children (aged <15 years) and AYAs (aged 15-39 years) despite an increase in incidence rates from 2001 to 2017. Overall cancer incidence rates in children and AYA increased in all racial/ethnic groups except American Indian/Alaska Native (AI/AN) children where rates remained stable. The most common cancer among AYA was female breast cancer.
“When evaluating health disparities, it is critical to acknowledge the social factors that influence the health of the communities and access to health care,” said Betsy A. Kohler, MPH, NAACCR Executive Director. “Social and economic indicators, particularly based on small area assessments, are increasingly important to understanding the burden of cancer.”
The authors indicate these findings can help inform healthcare providers about the need to increase efforts related to cancer prevention, early detection, and treatment, and for the need for equitable implementation of effective interventions, especially among under-resourced populations.
Email address is optional. If provided, your email will not be published or shared.
SciTechDaily: Home of the best science and technology news since 1998. Keep up with the latest scitech news via email or social media.
A new study from the University of California, Davis and the Icahn School of Medicine at Mount Sinai confirms that surgical masks effectively reduce outgoing…
Copyright © 1998 - 2021 SciTechDaily. All Rights Reserved.